(CRSP) Crispr Therapeutics complete technical analysis [charts+indicators] | Buy/Sell Crispr Therapeutics | (CRSP) share price targets
Complete technical analysis of Crispr Therapeutics (CRSP) by charts plus indicators, forecast predictions and share price targets for Crispr Therapeutics (CRSP)
Crispr Therapeutics trades in USA in Health Care sector.
Showing technical analysis as on 2025-03-04 View latest technical analysis
10 day averaged volume of Crispr Therapeutics is 2691470
Date | Daily Closing Price | Open | High | Low | Volume |
04 Tue Mar 2025 | 43.45 | 40.72 | 44.32 | 40.52 | 0.786 times |
03 Mon Mar 2025 | 42.29 | 45.16 | 45.20 | 42.10 | 0.641 times |
28 Fri Feb 2025 | 43.92 | 42.62 | 44.51 | 42.00 | 0.618 times |
27 Thu Feb 2025 | 43.62 | 44.57 | 46.78 | 43.51 | 0.551 times |
26 Wed Feb 2025 | 44.40 | 44.88 | 46.00 | 43.97 | 0.461 times |
25 Tue Feb 2025 | 44.51 | 46.23 | 46.67 | 44.02 | 0.801 times |
24 Mon Feb 2025 | 46.57 | 46.69 | 47.66 | 45.10 | 0.819 times |
21 Fri Feb 2025 | 47.91 | 51.23 | 51.47 | 47.34 | 0.994 times |
20 Thu Feb 2025 | 50.43 | 52.58 | 52.77 | 49.22 | 1.105 times |
19 Wed Feb 2025 | 53.02 | 52.40 | 55.88 | 52.23 | 1.771 times |
My analysis of stock is bearish for shortterm, and stock might move down till 40.5 or till 35.6. Use a stoploss of 44.55 and if the stock hits stoploss, then it can shoot up till 48.61
Share price targets for Crispr Therapeutics (CRSP)
Target Type | Value |
Downside Target | 36.52 |
Downside Target | 38.20 |
Downside Target | 39.21 |
Downside Target | 40.52 |
Downside Target | 42.00 |
Downside Target | 42.88 |
Upside Target | 45.20 |
Upside Target | 47.34 |
Upside Target | 47.66 |
Upside Target | 52.60 |
Upside Target | 53.97 |
Upside Target | 55.88 |
Upside Target | 59.07 |
Intraday share price targets for Crispr Therapeutics (CRSP)
Target Type | Value |
Downside Intraday Target | 40.91 |
Downside Intraday Target | 38.38 |
Upside Intraday Target | 45.59 |
Upside Intraday Target | 47.74 |
Downside Intraday Target | 43.06 |
Weekly technical analysis of Crispr Therapeutics (CRSP)
Date | Weekly Closing Price | Open | High | Low | Volume |
04 Tue Mar 2025 | 43.45 | 45.16 | 45.20 | 40.52 | 0.439 times |
28 Fri Feb 2025 | 43.92 | 46.69 | 47.66 | 42.00 | 0.532 times |
21 Fri Feb 2025 | 47.91 | 52.24 | 55.88 | 47.34 | 0.94 times |
14 Fri Feb 2025 | 49.72 | 40.00 | 52.60 | 38.28 | 1.87 times |
07 Fri Feb 2025 | 39.71 | 40.19 | 42.88 | 39.21 | 1.152 times |
Price has moved down this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Crispr Therapeutics (CRSP)
Date | Monthly Closing Price | Open | High | Low | Volume |
04 Tue Mar 2025 | 43.45 | 45.16 | 45.20 | 40.52 | 0.074 times |
28 Fri Feb 2025 | 43.92 | 40.19 | 55.88 | 38.28 | 1.242 times |
31 Fri Jan 2025 | 41.59 | 39.81 | 45.77 | 36.52 | 1.388 times |
31 Tue Dec 2024 | 39.36 | 53.00 | 53.97 | 38.20 | 0.8 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Crispr Therapeutics (CRSP)
Price action analysis of Crispr Therapeutics ( (CRSP) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Crispr Therapeutics ( (CRSP) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Crispr Therapeutics ( (CRSP) ) based on a short to mid term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Crispr Therapeutics ( (CRSP) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Crispr Therapeutics stock for short term is SELL. Signal strength is Weak and stock is gaining momentum.
MACD generated a SELL signal for Crispr Therapeutics in short term but the sell signal is initial and weak.
Crispr Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up
CCI has generated a SELL signal for Crispr Therapeutics in short term and SELL signal is strong!
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Crispr Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 47.26 and Crispr Therapeutics (CRSP) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Crispr Therapeutics (CRSP) stock. Volume based technical analysis of Crispr Therapeutics (CRSP) stock is negative.
Crispr Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Crispr Therapeutics ( (CRSP) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Crispr Therapeutics ( (CRSP) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Crispr Therapeutics ( (CRSP) ) based on a short to mid term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Crispr Therapeutics ( (CRSP) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Crispr Therapeutics stock for short term is SELL. Signal strength is Weak and stock is gaining momentum.
MACD generated a SELL signal for Crispr Therapeutics in short term but the sell signal is initial and weak.
Crispr Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up
CCI has generated a SELL signal for Crispr Therapeutics in short term and SELL signal is strong!
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Crispr Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 47.26 and Crispr Therapeutics (CRSP) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Crispr Therapeutics (CRSP) stock. Volume based technical analysis of Crispr Therapeutics (CRSP) stock is negative.
Crispr Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.